Factors associated with aGVHD in multivariate analysis
| Variable . | Relative risk (95% CI) . | P . |
|---|---|---|
| Patient sex | ||
| Male | 1.00 | |
| Female | 1.64 (1.12-2.41) | .010 |
| Patient age | ||
| 42 y or less | 1.00 | |
| More than 42 y | 1.70 (1.55-2.51) | .007 |
| CD34+ cells, × 106/kg | ||
| (1) 2 or less | 1.00 | P = .021 |
| (2) More than 2 to 4 | 2.02 (0.98-4.20) | P12 = .058 |
| (3) More than 4 | 2.62 (1.30-5.28) | P13 = .007 |
| CD3+ cells, × 106/kg | ||
| (1) 0.05 or less | 1.00 | P = .022 |
| (2) More than 0.05 to 0.1 | 2.06 (1.01-4.18) | P12 = .045 |
| (3) More than 0.1 | 2.45 (1.29-4.62) | P13 = .006 |
| Variable . | Relative risk (95% CI) . | P . |
|---|---|---|
| Patient sex | ||
| Male | 1.00 | |
| Female | 1.64 (1.12-2.41) | .010 |
| Patient age | ||
| 42 y or less | 1.00 | |
| More than 42 y | 1.70 (1.55-2.51) | .007 |
| CD34+ cells, × 106/kg | ||
| (1) 2 or less | 1.00 | P = .021 |
| (2) More than 2 to 4 | 2.02 (0.98-4.20) | P12 = .058 |
| (3) More than 4 | 2.62 (1.30-5.28) | P13 = .007 |
| CD3+ cells, × 106/kg | ||
| (1) 0.05 or less | 1.00 | P = .022 |
| (2) More than 0.05 to 0.1 | 2.06 (1.01-4.18) | P12 = .045 |
| (3) More than 0.1 | 2.45 (1.29-4.62) | P13 = .006 |
indicates 2 degrees of freedom;P12, probability of testing (1) = (2); andP13, probability of testing (1) = (3).